Relapse of lupus nephritis induced by nivolumab in an 84-year-old patient with oral cancer: a case report

Various immunity-related adverse events have been reported to be associated with the inhibition of programmed cell death receptor 1. We report a rare case of a relapse of lupus nephritis (LN), involving rapidly progressive glomerulonephritis, which was induced by nivolumab treatment in a patient wit...

Full description

Bibliographic Details
Main Authors: Zhou Zhou, Qiankun Zhang, Xinbin Wang
Format: Article
Language:English
Published: SAGE Publishing 2023-09-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/03000605231202140
Description
Summary:Various immunity-related adverse events have been reported to be associated with the inhibition of programmed cell death receptor 1. We report a rare case of a relapse of lupus nephritis (LN), involving rapidly progressive glomerulonephritis, which was induced by nivolumab treatment in a patient with oral cancer. The patient had a history of systemic lupus erythematosus and underwent treatment with steroids, rituximab, and plasmapheresis. However, her renal function did not improve, and she died of multiple organ failure. To our knowledge, this is the first description of severe LN induced by nivolumab.
ISSN:1473-2300